Skip to main content

Cadre Holdings, Inc. (CDRE) Stock Forecast

Data as of Aug 1, 2026

Industrials · Current price $30.85 (+0.82%)

Consensus Target
$44.33
Upside
+43.0%
Analysts
1
Rating
Buy(2.00)

Price Target Range

Low $40.00Consensus $44.33High $53.00
▲ Current $30.85

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

No rating trend data.

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Feb 3, 2026Matt KorandaRoth Capital$50.00+62.1%

CDRE vs Sector & Market

MetricCDREIndustrials AvgLarge Cap Avg
Analyst Rating2.002.402.42
Analyst Count1819
Target Upside+43.0%+109.0%+18.0%
P/E Ratio34.6636.6343.33

Revenue Estimates

PeriodLowAvgHigh#
2026-09-30$189M$190M$192M2
2026-12-31$205M$207M$209M3
2027-12-31$776M$791M$814M3
2028-12-31$852M$863M$881M2

EPS Estimates

PeriodLowAvgHigh#
2026-09-30$0.37$0.37$0.381
2026-12-31$0.42$0.42$0.431
2027-12-31$1.42$1.50$1.562
2028-12-31$1.58$1.84$2.102

Frequently Asked Questions

What is the analyst consensus for CDRE?

The consensus among 1 analysts covering Cadre Holdings, Inc. (CDRE) is Buy with an average price target of $44.33.

What is the highest price target for CDRE?

The highest price target for CDRE is $50.00, set by Matt Koranda at Roth Capital on 2026-02-03.

What is the lowest price target for CDRE?

The lowest price target for CDRE is $50.00, set by Matt Koranda at Roth Capital on 2026-02-03.

How many analysts cover CDRE?

1 analysts have issued ratings for Cadre Holdings, Inc. in the past 12 months.

Is CDRE a buy or sell right now?

Based on 1 analyst ratings, CDRE has a consensus rating of Buy (2.00/5) with a +43.0% upside to the consensus target of $44.33.

What are the earnings estimates for CDRE?

Analysts estimate CDRE will report EPS of $0.37 for the period ending 2026-09-30, with revenue estimated at $190M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.